DrugDashboards

Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate · DEXTROAMPHETAMINE SACCHARATE 5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; DEXTROAMPHETAMINE SULFATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1 · Tablet · Oral · SpecGx LLC

NDC 00406-8893-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price is down 9% over the past year, to $0.2946 per unit. It is in shortage right now — FDA lists the reason as “demand increase for the drug”. Put together: this is a fragile supply — if anything else goes wrong, there is very little slack to absorb it.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.2946per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Federal contracts pay (FSS)$0.4280per unitSpecGx LLC · Mar 22, 2025145% of what pharmacies pay — higher than 67% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$0.2971per TABweighted avg manufacturer price $0.1698 · Aug 1, 2026101% of what pharmacies pay — higher than 57% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Mar 2014Sep 2026$0.2946
143 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$8.84
#90 count
$26.52

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$1.1M
44,513 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

55● High risk

Several kinds of pressure are visible at once — each line below is a condition that historically precedes supply trouble, and this market is stacking them.

  • 1 active manufacturer+30
  • in shortage now+25

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA040440
TE code
AB
Approval date
Oct 7, 2003
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01)Oct 12, 2022
    Demand increase for the drug
    month 47 — 3× the typical 14-month oral solid shortage
  • In shortage now — Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01)Oct 12, 2022
    month 47 — 3× the typical 14-month oral solid shortage
  • In shortage now — Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01)Oct 12, 2022
    Demand increase for the drug
    month 47 — 3× the typical 14-month oral solid shortage
  • In shortage now — Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01)Oct 12, 2022
    month 47 — 3× the typical 14-month oral solid shortage
  • In shortage now — Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01)Oct 12, 2022
    month 47 — 3× the typical 14-month oral solid shortage
  • In shortage now — Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)Oct 12, 2022
    Demand increase for the drug
    month 47 — 3× the typical 14-month oral solid shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate (Tablet)

LabelerStrengthFirst seenLast seen
SpecGx LLCDEXTROAMPHETAMINE SACCHARATE 7.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; DEXTROAMPHETAMINE SULFATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1Jul 22, 2026Sep 2, 2026
SpecGx LLCDEXTROAMPHETAMINE SACCHARATE 1.25 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; DEXTROAMPHETAMINE SULFATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1Jul 22, 2026Sep 2, 2026
SpecGx LLCDEXTROAMPHETAMINE SACCHARATE 1.875 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; DEXTROAMPHETAMINE SULFATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1Jul 22, 2026Sep 2, 2026
SpecGx LLCDEXTROAMPHETAMINE SACCHARATE 2.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; DEXTROAMPHETAMINE SULFATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1Jul 22, 2026Sep 2, 2026
SpecGx LLCDEXTROAMPHETAMINE SACCHARATE 3.75 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; DEXTROAMPHETAMINE SULFATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1Jul 22, 2026Sep 2, 2026
SpecGx LLCDEXTROAMPHETAMINE SACCHARATE 5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; DEXTROAMPHETAMINE SULFATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1Jul 22, 2026Sep 2, 2026
SpecGx LLCAMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXTROAMPHETAMINE SACCHARATE 1.25 mg/1; DEXTROAMPHETAMINE SULFATE 1.25 mg/1Jul 15, 2026Jul 15, 2026
SpecGx LLCAMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DEXTROAMPHETAMINE SACCHARATE 1.875 mg/1; DEXTROAMPHETAMINE SULFATE 1.875 mg/1Jul 15, 2026Jul 15, 2026
SpecGx LLCAMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 2.5 mg/1; DEXTROAMPHETAMINE SULFATE 2.5 mg/1Jul 15, 2026Jul 15, 2026
SpecGx LLCAMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXTROAMPHETAMINE SACCHARATE 3.75 mg/1; DEXTROAMPHETAMINE SULFATE 3.75 mg/1Jul 15, 2026Jul 15, 2026
SpecGx LLCAMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPHETAMINE SACCHARATE 5 mg/1; DEXTROAMPHETAMINE SULFATE 5 mg/1Jul 15, 2026Jul 15, 2026
SpecGx LLCAMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 7.5 mg/1; DEXTROAMPHETAMINE SULFATE 7.5 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate — NDC 00406-8893-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00406889301.

Free to cite with attribution — see how the data is put together.